CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Sample Collection for Genome-Wide Sequencingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01345513
NCT01345513N/ACompleted
CompareCT.gov

Feasibility Clinical Study of Targeted and Genome-Wide Sequencing

University Health Network, Toronto·observational·Posted May 2, 2011·Updated Mar 23, 2020

In Brief

An observational study evaluating Sample Collection for Genome-Wide Sequencing for Solid Tumors. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This research is being done to find out what types of gene mutations are present in people with cancer. This study is designed to help researchers and doctors understand more about cancer. With this information, doctors may have a better idea as to which cancer treatments are most appropriate for certain patients. The information will also help researchers find out the how to identify genes in cancers from biopsies and blood samples and how to use this information to help doctors and patients make treatment decisions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSolid Tumors
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 2, 2011
Enrollment StartMar 1, 2011
Primary CompletionMar 25, 2013
Study CompletionJan 21, 2019
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 15.2 years ago

Interventions

Sample Collection for Genome-Wide Sequencingother

Collection of archival tumor tissue, fresh tumor biopsy, blood sample, and pleural effusion (if available)or ascites (if available)